Engelson Erik T. 4
4 · Lucira Health, Inc. · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Engelson Erik T.
DirectorPresident and Chief Executive
Transactions
- Conversion
Common Stock
2021-02-09+23,282→ 23,282 total - Conversion
Series C Preferred Stock
2021-02-09−23,282→ 0 total→ Common Stock (23,282 underlying)
Holdings
- 191,705(indirect: See footnote)
Common Stock
- 46,400(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Each share of Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.
- [F2]The shares are held by the Elisabeth North Keuchler Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
- [F3]The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.